VR-Based Optokinetic Stimulation in Multiple Sclerosis
Acute Effects of Virtual Reality-Based Optokinetic Stimulation in Individuals With Multiple Sclerosis: Does Central Vestibular Dysfunction Alter These Effects?
What it found
No result yet.
What was tested
Treatment tested
- Virtual Reality-Based Optokinetic Stimulation (OKS)
What it measured
Main measures
Postural Sway
Immediately before and immediately after the 10-minute virtual reality-based optokinetic stimulation session
Who could take part
MS (type not specified) · 18 to 55
Show the full criteria
Inclusion criteria
* Be an adult aged 18-55 years * Have a confirmed diagnosis of MS by a neurologist (for MS groups) * Not have had a relapse in the last 3 months (for MS patients) * Have an Expanded Disability Status Scale (EDSS) score of ≤ 4 (for MS patients) * Be a healthy control with no condition preventing participation
Exclusion criteria
* Have peripheral vestibular dysfunction (for MS groups) * Be older than 55 years * Have any cardiovascular, orthopedic, neurological, or other condition preventing assessments * Have a history of neurological disorders, head trauma, or chronic psychiatric conditions (for healthy controls)
As registered. Criteria can change, so ask the trial team or your neurologist.
Contact details on the registryAbout this trial
In the sponsor's words
The aim of this study is to investigate the acute effects of virtual reality-based optokinetic stimulation on postural sway and motion sickness symptoms in individuals with multiple sclerosis (MS)
Loading reviews and guidelines…
History
Started
Sept 2025
Main results due
Oct 2025
Finished
Oct 2025